A third edition of the ASH guidelines on immune thrombocytopenia are expected to be published in 2019. These guidelines, which address the management of both children and adults, update prior editions published in 1996 and 2011. The new edition was developed using updated methods, by an international panel that included research experts, clinicians, and patient representatives. Systematic evidence review was supported by the University of Oklahoma Health Sciences Center.
In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice.